Headline
The latest stories from AHA Today.
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to severe acute pain in adults.
The Cybersecurity and Infrastructure Security Agency and Food and Drug Administration Jan. 30 released notices warning of vulnerabilities found in the Contec CMS8000, a patient monitoring device used to display patient vital signs. The vulnerabilities also apply to Epsimed MN-120 patient monitors,…
The AHA yesterday released an advisory alerting members that the association and the Health Information Sharing and Analysis Center have identified attempted and ongoing ransomware attacks potentially due to SimpleHelp remote access software vulnerabilities. Health care organizations are advised to…
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal grants, loans and other financial assistance programs implicated by President Trump’s recent executive orders.
Baxter Jan. 28 announced that IV solutions production has been restarted on all manufacturing lines at its North Carolina site impacted by Hurricane Helene in October.
An analysis by KFF released Jan. 28 found that Medicare Advantage insurers made nearly 50 million prior authorization determinations in 2023. The finding reflects continued year-over-year increases from 2022 (42 million) and 2021 (37 million) as more people have enrolled in MA. KFF also found that…
The AHA Jan. 28 voiced support for bipartisan legislation to reauthorize for five years the Dr. Lorna Breen Health Care Provider Protection Act, which provides grants to help health care organizations offer behavioral health services for front-line health care workers.
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other financial assistance programs implicated by President Trump’s recent executive orders.
Dementia cases in the U.S. are expected to double by 2060, reaching 1 million new cases per year, according to a study released Jan. 13 by NYU Langone Health.
The ransomware attack last year against UnitedHealth Group subsidiary Change Healthcare exposed data of more than 190 million people — up from previous reports of 100 million — according to multiple outlets Jan. 24.